Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (221-230 of 293) with videos related to

Pageof 30
Sort By:
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsClémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2022
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver diseaseGrazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseZobair M Younossi, Maria Stepanova, Janus Ong, et al.
Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.
Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Hepatology (Baltimore, Md.)|March 4, 2026
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favouring MASLD-Related HCC immune evasionJessica Nurcis, Beatrice Foglia, Chiara Rosso, et al.
Journal of Hepatology|April 11, 2022
Rare ATG7 genetic variants predispose patients to severe fatty liver diseaseGuido A Baselli, Oveis Jamialahmadi, Serena Pelusi, et al.
Pageof 30

Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsClémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2022
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver diseaseGrazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseZobair M Younossi, Maria Stepanova, Janus Ong, et al.
Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.
Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Hepatology (Baltimore, Md.)|March 4, 2026
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favouring MASLD-Related HCC immune evasionJessica Nurcis, Beatrice Foglia, Chiara Rosso, et al.
Journal of Hepatology|April 11, 2022
Rare ATG7 genetic variants predispose patients to severe fatty liver diseaseGuido A Baselli, Oveis Jamialahmadi, Serena Pelusi, et al.
Pageof 30